Kimberly Ann Davis
Investor Relations Contact chez ZURA BIO LIMITED
Fortune : 218 072 $ au 30/04/2024
Profil
Kimberly Ann Davis is currently working as the Secretary, Chief Legal Officer & Executive VP at Zura Bio Ltd.
She previously worked as the Executive Director at Amgen, Inc. from 2008 to 2011.
From 2011 to 2014, she held the position of Vice President & Compliance Officer at Impax Laboratories LLC.
Ms. Davis also served as the Chief Compliance Officer & Vice President at Arena Pharmaceuticals, Inc. from 2020 to 2022.
Prior to that, she worked as the Chief Compliance Officer & Vice President at Kaleo, Inc. from 2014 to 2020.
Ms. Davis completed her undergraduate degree at Sweet Briar College and obtained her graduate degree from Pepperdine University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A
0,14% | 25/03/2024 | 60 241 ( 0,14% ) | 218 072 $ | 30/04/2024 |
Postes actifs de Kimberly Ann Davis
| Sociétés | Poste | Début |
|---|---|---|
| ZURA BIO LIMITED | Investor Relations Contact | 01/09/2022 |
Anciens postes connus de Kimberly Ann Davis
| Sociétés | Poste | Fin |
|---|---|---|
| ARENA PHARMACEUTICALS | Compliance Officer | 01/09/2022 |
Kaleo, Inc.
 Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Compliance Officer | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Compliance Officer | 01/01/2014 |
| AMGEN INC. | Directeur/Membre du Conseil | 01/01/2011 |
Formation de Kimberly Ann Davis
| Pepperdine University School of Law | Graduate Degree |
| Sweet Briar College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZURA BIO LIMITED | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
